Wednesday, April 22, 2015 9:00:28 PM
After listening to the conference call the biggest take away is GW expanding epidiolex in TCS research.. Epidiolex is a pipeline of drugs in just one.. GW is going to continue to use epidiolex to launch new trails to treat even more diseases than just epilepsy.
Looks for profit take for the next few months until data is released again. trading should be similar to what we saw in 2014.. The end of 2015 new highs will be reached pending the final results from the dravet trails. I will be adding to this position during any periods of profit taking. Good luck to all.
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM